2016年2期
刊物介紹
Cancer Biology & Medicine is a peer-reviewed open-access journal of Chinese Anti-cancer Association (CACA), which is the leading professional society of oncology in China. The journal quarterly provides innovative and significant information on biological basis of cancer, cancer microenvironment, translational cancer research, and all aspects of clinical cancer research. The journal also publishes significant perspectives on indigenous cancer types in China. The scope covers the following topics: ● Cancer epigenetics ● Cancer stem cell ● Improved in vivo and in vitro cancer models ● Cancer prevention and epidemiology ● Biomarkers for predicting drug response ● Mechanism of drug sensitivity and resistance ● New approaches for cancer detection and diagnosis ● Oncology clinical trials ● Targeted therapy ● Multidisciplinary treatment for cancer Author benefits: ● Easy online submission via Editorial Manager ● Efficient and professional peer-review by expert referees from around the world ● Rapid pre-print online publication ● No charge for publication and Open Access ● International visibility - the journal is available free online
Cancer Biology & Medicine
REVIEW （2016年02期）
- Immuno-oncology combinations: raising the tail of the survival curve
- Nonmuscle invasive bladder cancer: a primer on immunotherapy
- Relationship of VEGF/VEGFR with immune and cancer cells: staggering or forward？
- New generation of breast cancer clinical trials implementing molecular profiling
- Genetic and molecular changes in ovarian cancer
- Bone marrow niche-mediated survival of leukemia stem cells in acute myeloid leukemia: Yin and Yang
- Characterization of FGFR signaling pathway as therapeutic targets for sarcoma patients
- Influence of obesity and bariatric surgery on gastric cancer
- Modulation of B-cell receptor and microenvironment signaling by a guanine exchange factor in B-cell malignancies
- The oncofetal protein IMP3 is an indicator of early recurrence and poor outcome in mucoepidermoid carcinoma of salivary glands